Latest Breaking News On - Chief executive peter keeling - Page 1 : comparemela.com

By Michael Susin Diaceutics reported a widened pretax loss for the first half of 2023, driven by higher costs despite a revenue jump, but backed its.

Michael susinRyan keelingPeter keelingChief executive peter keelingChief innovation officer ryan keelingArticle normalHealthcare life sciencesHealthcare support servicesDiagnostic medical research servicesFinancial performanceManagement movesCorporate industrial newsSenior level managementContent typesFactiva filtersC amp ampe executive news filter